eFigure 1. Study flowchart showing the numbers of participants through each stage of the study. Tan boxes represent the sample in the case-control study and blue boxes include the patients with major depressive disorder enrolled in the 1-week placebo lead-in, 8-week double-blind and randomized pharmacogenetic study of antidepressant treatment. BDNF indicates brain-derived neurotrophic factor gene; ITT, intention-to-treat sample. eFigure 2. Estimated population structure using 54 unlinked single-nucleotide polymorphisms (SNPs). In the rectangles on the left, each individual is represented by a single vertical line, which is broken into K colored segments, with lengths proportional to each of the K clusters inferred from the STRUCTURE program using the genotype download from the HapMap database (A) and Mexican American patients with major depressive disorder (MDD) and healthy controls in the sample (B) separately. In the triangle plots on the right, each individual is represented by a colored point corresponding to the predefined population. For a given point, the estimate is given by the distance to 1 edge of the triangle. 
